AbCellera Biologics (ABCL) Gross Profit (2021 - 2023)
AbCellera Biologics' (ABCL) quarterly Gross Profit came in at $9.2 million in Q4 2023, down 54.21% YoY from $20.0 million in Q4 2022, and up 39.1% on a QoQ basis from $6.6 million in Q3 2023.
AbCellera Biologics (ABCL) Gross Profit (2021 - 2023) Analysis & Trends
AbCellera Biologics (ABCL) has 3 years of Gross Profit data on file, last reported at $9.2 million in Q4 2023.
- Quarterly Gross Profit fell 54.21% year-over-year to $9.2 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $38.0 million (down 90.93% YoY) and the FY2024 annual result came in at $28.8 million, down 24.17% from the prior year.
- Gross Profit improved to $9.2 million in Q4 2023, from $6.6 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $271.9 million in Q1 2022 to a low of $5.5 million in Q3 2021.
- A 3-year average of $65.6 million and a median of $22.0 million in 2021 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2022 — Gross Profit jumped 1468.32% — and 2023, when it plunged 95.52%.
- Tracing ABCL's Gross Profit over 3 years: stood at $117.4 million in 2021, then plunged by 82.93% to $20.0 million in 2022, then plunged by 54.21% to $9.2 million in 2023.
- The last three Gross Profit figures came in at $9.2 million (Q4 2023), $6.6 million (Q3 2023), and $10.1 million (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 9.18 Mn |
| Dec 31, 2023 | 9.18 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 10.06 Mn |
| Jun 30, 2023 | 10.06 Mn |
| Mar 31, 2023 | 12.19 Mn |
| Mar 31, 2023 | 12.19 Mn |
| Dec 31, 2022 | 20.05 Mn |
| Dec 31, 2022 | 20.05 Mn |
| Sep 30, 2022 | 86.38 Mn |
| Sep 30, 2022 | 86.38 Mn |
| Jun 30, 2022 | 40.71 Mn |
| Jun 30, 2022 | 40.71 Mn |
| Mar 31, 2022 | 271.94 Mn |
| Mar 31, 2022 | 271.94 Mn |
| Dec 31, 2021 | 117.44 Mn |
| Dec 31, 2021 | 117.44 Mn |
| Sep 30, 2021 | 5.51 Mn |
| Sep 30, 2021 | 5.51 Mn |